VDRM (ViaDerma) ROC %: 10.58% (As of Jun. 2012)


What is ViaDerma ROC %?

ViaDerma VDRM -25.00% ROC % is 10.58% as of Jun. 2012.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. ViaDerma's annualized return on capital (ROC %) for the quarter that ended in Jun. 2012 was 10.58%.

As of today (2026-06-25), ViaDerma's WACC % is 0.00%. ViaDerma's ROC % is 0.00% (calculated using TTM income statement data). ViaDerma earns returns that do not match up to its cost of capital. It will destroy value as it grows.

ViaDerma  (OTCPK:VDRM) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, ViaDerma's WACC % is 0.00%. ViaDerma's ROC % is 0.00% (calculated using TTM income statement data). ViaDerma earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

ViaDerma ROC % Related Terms

ViaDerma ROC % Historical Data

* Premium members only.

The historical data trend for ViaDerma's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ViaDerma ROC % Chart

ViaDerma Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
ROC %
-1,762.50 69.08 18.91 18.22 8.26

ViaDerma Quarterly Data
Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.27 5.24 6.68 5.30 10.58

ViaDerma ROC % Calculation

ViaDerma's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2011 is calculated as:

ROC % (A: Dec. 2011 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2010 ) + Invested Capital (A: Dec. 2011 ))/ count )
=4.039 * ( 1 - 24.64% )/( (33.054 + 40.658)/ 2 )
=3.0437904/36.856
=8.26 %

where

Invested Capital(A: Dec. 2010 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=36.074 - 2.047 - ( 0.973 - max(0, 5.808 - 15.751+0.973))
=33.054

Invested Capital(A: Dec. 2011 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=42.645 - 1.409 - ( 0.578 - max(0, 5.765 - 14.767+0.578))
=40.658

ViaDerma's annualized Return on Capital (ROC %) for the quarter that ended in Jun. 2012 is calculated as:

ROC % (Q: Jun. 2012 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2012 ) + Invested Capital (Q: Jun. 2012 ))/ count )
=6.084 * ( 1 - 28.75% )/( (40.786 + 41.193)/ 2 )
=4.33485/40.9895
=10.58 %

where

Invested Capital(Q: Mar. 2012 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=44.93 - 2.774 - ( 1.37 - max(0, 7.719 - 17.218+1.37))
=40.786

Invested Capital(Q: Jun. 2012 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=45.832 - 3.452 - ( 1.187 - max(0, 7.872 - 16.925+1.187))
=41.193

Note: The Operating Income data used here is four times the quarterly (Jun. 2012) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of 10.58% mean?
ViaDerma (VDRM) has a ROC % of 10.58% as of Jun. 2012. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on ViaDerma and its competitors.
Is ViaDerma's ROC % too high?
ViaDerma's current ROC % is 10.58%. The Drug Manufacturers industry median ROC % is 4.44. ViaDerma's value of 10.58% is 138.3% above this industry median.
How does ViaDerma's ROC % compare to AOLS and RDGL?
ViaDerma's ROC % of 10.58% can be compared against companies in the Drug Manufacturers industry. The industry median ROC % is 4.44. ViaDerma's value of 10.58% is 138.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Drug Manufacturers company?
The median ROC % among Drug Manufacturers companies is 4.44, based on 985 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ViaDerma's current ROC % of 10.58% is 138.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on ViaDerma and its competitors. For the Drug Manufacturers industry, the median ROC % is 4.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ViaDerma's current ROC % is 10.58%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ViaDerma stock overvalued right now?
ViaDerma (VDRM) has a current ROC % of 10.58%. The current ROC % is 10.58% and 138.3% above the Drug Manufacturers industry median of 4.44. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For ViaDerma (VDRM), the current ROC % is 10.58% as of Jun. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ViaDerma Business Description

Address 4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292
ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.